Fitzgerald Kevin Joseph Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
9
Insider Sells Sum
$8.32M

Insider Activity of Fitzgerald Kevin Joseph

According to the SEC Form 4 filings, Fitzgerald Kevin Joseph, being in a position of

  1. CSO & EVP, Head of Research at Alnylam Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 24469 shares for $9.63M,
    over all time since 2024-06-25, has bought 0 shares, and sold 59883 shares for $19.69M.

Biography of Fitzgerald Kevin Joseph

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $9,634,4209100

Comparison of Insiders on Amount of Buys and Sells

2026-03-05SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
658
0.0005%
$323.98$213,177-10.71%
2026-03-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
633
0.0005%
$323.08$204,508-12.54%
2026-03-03SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
1,652
0.0012%
$319.73$528,189-10.14%
2026-03-02SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
1,598
0.0012%
$327.65$523,584-11.89%
2026-02-17SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
2,041
0.0015%
$331.96$677,532-13.38%
2026-02-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
1,959
0.0015%
$310.08$607,448-8.34%
2026-01-13SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
2,290
0.0017%
$370.33$848,065-20.66%
2026-01-12SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
1,510
0.0011%
$362.87$547,927-20.79%
2025-11-17SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
12,128
0.009%
$452.18$5.48M-34.43%
2025-10-02SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
2,441
0.0018%
$452.05$1.1M-31.16%
2025-08-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
1,396
0.0011%
$453.27$632,759-27.2%
2025-03-04SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
844
0.0006%
$241.15$203,532+44.82%
2025-03-03SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
1,911
0.0015%
$243.73$465,772+44.46%
2025-02-28SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
496
0.0004%
$241.69$119,878+42.61%
2025-02-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
1,440
0.0011%
$251.56$362,243+40.72%
2025-02-14SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
663
0.0005%
$255.21$169,204+37.21%
2024-11-27SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
1,531
0.0012%
$252.29$386,261+18.56%
2024-11-26SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
1,469
0.0011%
$250.98$368,686+18.3%
2024-08-12SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
22,025
0.0172%
$270.99$5.97M-0.07%
2024-06-25SaleAlnylam Pharmaceuticals, Inc.
ALNY
CSO & EVP, Head of Research
1,198
0.0009%
$230.99$276,731+9.36%
Total: 20
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.